Pharmacogenetics of tardive dyskinesia: Combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism

Lerer, B. et al. (2002) Pharmacogenetics of tardive dyskinesia: Combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism. Neuropsychopharmacology, 27(1), pp. 105-119.

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McCreadie, Prof Robin
Authors: Lerer, B., Segman, R., Fangerau, H., Daly, A., Basile, V., Cavallaro, R., Aschauer, H., McCreadie, R., Ohlraun, S., Ferrier, N., Masellis, M., Verga, M., Scharfetter, J., Rietschel, M., Lovlie, R., Levy, U., Meltzer, H., Kennedy, J., Steen, V., and Macciardi, F.
College/School:College of Medical Veterinary and Life Sciences
Journal Name:Neuropsychopharmacology

University Staff: Request a correction | Enlighten Editors: Update this record